CCI
30
2
HCP
52
5
NSC
54
-2
EXPD
45
-5
MMM
44
9
QCOM
57
-2
HRB
56
-4
MLM
50
2
WHR
61
2
FOX
59
17
LYB
36
2
GD
41
-3
CB
43
3
FSLR
47
-3
PRGO
35
-4
KR
49
5
DGX
33
-2
INTC
31
-4
LEN
49
-4
PHM
58
-2
CCI
30
2
HCP
52
5
NSC
54
-2
EXPD
45
-5
MMM
44
9
QCOM
57
-2
HRB
56
-4
MLM
50
2
WHR
61
2
FOX
59
17
LYB
36
2
GD
41
-3
CB
43
3
FSLR
47
-3
PRGO
35
-4
KR
49
5
DGX
33
-2
INTC
31
-4
LEN
49
-4
PHM
58
-2
Financhill
Back

Dyne Therapeutics Stock Predictions

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE
Sell
35

DYN
Dyne Therapeutics

Last Price:
29.49
Seasonality Move:
27.54%

7 Day Trial

ALL ACCESS PASS

$ 7

A 10,000% Dividend?!?

Watch the short presentation by clicking here.

Dyne Therapeutics Stock Forecast

  • Over the next 52 weeks, Dyne Therapeutics has on average historically risen by 30.4% based on the past 4 years of stock performance.
  • Dyne Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
  • Is Dyne Therapeutics Stock Undervalued?
    The current Dyne Therapeutics [DYN] share price is $29.50. The Score for DYN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • DYN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Dyne Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Dyne Therapeutics has on average historically risen by 30.4% based on the past 4 years of stock performance.

Dyne Therapeutics Stock Rating

Sell
35
Dyne Therapeutics (DYN) is a Sell

Is Dyne Therapeutics overpriced?

  • Dyne Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%

Dyne Therapeutics Stock Price History

Is DYN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
dyne-tx.com

52-Week Data

52-Week High:
47.45
52-Week Low:
10.33

Prediction Charts

Market Cap:
3B
Price in USD:
29.50
Volume:
1.1M
Beta:
1.09

Technical Analysis

SMA50:
31.17
SMA100:
35.81
SMA200:
32.61
52-Wk Change:
158.32%

Stock Predictions

  • Is Dyne Therapeutics stock public?
    Yes, Dyne Therapeutics is a publicly traded company.
  • What is the Dyne Therapeutics stock quote today?
    The Dyne Therapeutics stock price is 29.50 USD today.
  • How to buy Dyne Therapeutics stock online?
    You can buy Dyne Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-18 28.28 29.34 29.66 27.04
Nov-19 28.89 29.68 29.70 28.13
Nov-20 29.47 29.99 30.28 28.68
Nov-21 30.42 29.73 30.85 29.35
Nov-22 30.00 29.69 30.37 29.18
Nov-25 29.63 29.45 30.77 29.19
Nov-26 29.92 29.23 29.98 28.60
Nov-27 29.62 31.13 31.32 28.80
Nov-29 31.25 30.61 31.29 29.73
Dec-2 30.45 29.28 30.46 29.26
Dec-3 28.95 28.17 29.42 27.99
Dec-4 28.27 29.44 29.57 27.93
Dec-5 29.05 27.74 29.52 27.68
Dec-6 27.95 29.50 29.59 27.70

Dyne Therapeutics Earnings

Dyne Therapeutics Earnings Report: Per Share Dyne Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Dyne Therapeutics Forecast Revenue Growth

Dyne Therapeutics Stock Analysis: Historical quarterly revenues per share for Dyne Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and a decrease next year of $0.06 per share.

* Dyne Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.